MRPL55 promotes BC progression as a prognostic biomarker by modulating lipogenesis and cyclin-dependent kinase pathways, from multi-omics to drug repurposing.

BACKGROUND: The mitochondrial ribosomal protein (MRP) family plays a pivotal role in tumorigenesis and has been linked to the advancement of various malignancies. Among them, MRPL55 has emerged as a protein of growing interest; however, its precise b…

Preview only. Read the full abstract at the source